Back to overview

Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death

Type of publication Peer-reviewed
Publikationsform Original article (peer-reviewed)
Author Casadellà Maria, Cozzi-Lepri Alessandro, Phillips Andrew, Noguera-Julian Marc, Bickel Markus, Sedlacek Dalibor, Zilmer Kai, Clotet Bonaventura, Lundgren Jens D., Paredes Roger,
Project Swiss HIV Cohort Study (SHCS)
Show all

Original article (peer-reviewed)

Journal PLOS ONE
Volume (Issue) 12(1)
Page(s) e0166613 - e0166613
Title of proceedings PLOS ONE
DOI 10.1371/journal.pone.0166613

Open Access

Type of Open Access Publisher (Gold Open Access)


Objective To investigate if plasma HIV-1 tropism testing could identify subjects at higher risk for clinical progression and death in routine clinical management. Design Nested case-control study within the EuroSIDA cohort. Methods Cases were subjects with AIDS or who died from any cause, with a plasma sample with HIV-1 RNA >1000 copies/mL available for tropism testing 3 to 12 months prior to the event. At least 1 control matched for age, HIV-1 RNA and HCV status at the time of sampling were selected per each case. Conditional logistic regression was used to investigate exposures associated with clinical progression to AIDS or death. A linear mixed model with random intercept was used to compare CD4+T-cell slopes by HIV tropism over the 12 months following the date of sampling. Results The study included 266 subjects, 100 cases and 166 controls; one quarter had X4 HIV; 26% were ART-naïve. Baseline factors independently associated with clinical progression or death were female gender (OR = 2.13 vs. male, 95CI = 1.04, 4.36), p = 0.038), CD4+T-cell count (OR = 0.90 (95CI = 0.80, 1.00) per 100 cells/mm3 higher, p = 0.058), being on ART (OR = 2.72 vs. being off-ART (95CI = 1.15, 6.41), p = 0.022) and calendar year of sample [OR = 0.84 (95CI = 0.77, 0.91) per more recent year, p<0.001). Baseline tropism was not associated with the risk of clinical progression or death. CD4+T-cell slopes did not differ within or between tropism groups. Conclusions The predictive role of plasma tropism determined using 454 sequencing in the context of people receiving cART with detectable VL is not helpful to identify subjects at higher risk for clinical progression to AIDS or death